Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 1Brain Neoplasms 1

Interventions

Blood Specimen Collection 55Surveys and Questionnaires 50Specimen Handling 27Radiotherapy 15Observation 15Magnetic Resonance Spectroscopy 12Data Collection 11Surgical Procedures, Operative 10Interviews as Topic 9Drug Therapy 9Biopsy 9darolutamide 8palbociclib 7Watchful Waiting 7Tomography, X-Ray Computed 7Standard of Care 7ribociclib 6Magnetic Resonance Imaging 6Genetic Testing 6Bevacizumab 6trastuzumab deruxtecan 5Ultrasonography 5Restraint, Physical 5Radiofrequency Ablation 5Patient Reported Outcome Measures 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Mass Screening 5Immune Checkpoint Inhibitors 5Breath Tests 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Fluorine-18 × 90 days × Clear all
NCT05937776 2026-06-05

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

OHSU Knight Cancer Institute

Completed
4 enrolled
CNS

Glioma

NCT06474533 2026-04-03

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

University of California, San Francisco

Recruiting
199 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡